Effects of biomaterial-induced inflammation on fibrosis and rejection

Seminars in Immunology

Volumn 20, Issue 2, 2008, Pages 130-136

  Jones, Kim S ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Adjuvant; Biomaterial; Combination products; Fibrosis; Transplant rejection

Indexed keywords

ALGINIC ACID; BIOMATERIAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PATTERN RECOGNITION RECEPTOR; POLYGLACTIN; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; BIOARTIFICIAL ORGAN; CD4+ T LYMPHOCYTE; CYTOKINE RELEASE; DENDRITIC CELL; FIBROSIS; GRAFT REJECTION; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; LYMPHANGIOGENESIS; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROENCAPSULATION; MIXED LYMPHOCYTE REACTION; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; SPLEEN CELL; T LYMPHOCYTE; TISSUE ENGINEERING; WOUND HEALING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL MOVEMENT; CRICETINAE; FIBROSIS; GRAFT REJECTION; HUMANS; INFLAMMATION; MACROPHAGE ACTIVATION; MICE; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TISSUE ENGINEERING; TRANSPLANTATION TOLERANCE;

EID: 40649094729     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2007.11.005     Document Type: Review

References (58)

1. Stocum D.L. Tissue restoration through regenerative biology and medicine. Adv Anat Embryol Cell Biol (2004) 176 [III-101, back]
2. Luttikhuizen D.T., Harmsen M.C., and van Luyn M.J. Cellular and molecular dynamics in the foreign body reaction. Tissue Eng 12 7 (2006) 1955-1970
3. Hamilton J.A. Nondisposable materials, chronic inflammation, and adjuvant action. J Leukoc Biol 73 6 (2003) 702-712
4. Anderson J.M. Mechanisms of inflammation and infection with implanted devices. Cardiovasc Pathol 2 Suppl. 3 (1993) 33S-41S
5. Robitaille R., Dusseault J., Henley N., Desbiens K., Labrecque N., and Halle J.P. Inflammatory response to peritoneal implantation of alginate-poly-l-lysine microcapsules. Biomaterials 26 19 (2005) 4119-4127
6. Thiele L., Diederichs J.E., Reszka R., Merkle H.P., and Walter E. Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells. Biomaterials 24 8 (2003) 1409-1418
7. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81 1 (2007) 1-5
8. Leid J.G., Willson C.J., Shirtliff M.E., Hassett D.J., Parsek M.R., and Jeffers A.K. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J Immunol 175 11 (2005) 7512-7518
9. Yang D, Jones KS. Alginate causes innate immune activation in macrophages. J Biomed Mater Res A; in press.
10. Jerala R. Structural biology of the LPS recognition. Int J Med Microbiol 297 5 (2007) 353-363
11. Delhalle S., Blasius R., Dicato M., and Diederich M. A beginner's guide to NF-kappaB signaling pathways. Ann N Y Acad Sci 1030 (2004) 1-13
12. Carmody R.J., and Chen Y.H. Nuclear factor-kappaB: activation and regulation during Toll-like receptor signaling. Cell Mol Immunol 4 1 (2007) 31-41
13. Flo T.H., Ryan L., Latz E., Takeuchi O., Monks B.G., Lien E., et al. Involvement of Toll-like receptor (TLR)2 and TLR4 in cell activation by mannuronic acid polymers. J Biol Chem 277 38 (2002) 35489-35495
14. Strieter R.M. Con: inflammatory mechanisms are not a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 165 9 (2002) 1206-1207
15. Gauldie J. Pro: inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 165 9 (2002) 1205-1206
16. Kelly M., Kolb M., Bonniaud P., and Gauldie J. Re-evaluation of fibrogenic cytokines in lung fibrosis. Curr Pharm Des 9 1 (2003) 39-49
17. Bonniaud P., Margetts P.J., Ask K., Flanders K., Gauldie J., and Kolb M. TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis. J Immunol 175 8 (2005) 5390-5395
18. Gauldie J., Kolb M., Ask K., Martin G., Bonniaud P., and Warburton D. Smad3 signaling involved in pulmonary fibrosis and emphysema. Proc Am Thorac Soc 3 8 (2006) 696-702
19. Gauldie J., Bonniaud P., Sime P., Ask K., and Kolb M. TGF-beta, Smad3 and the process of progressive fibrosis. Biochem Soc Trans 35 Pt 4 (2007) 661-664
20. Ask K., Bonniaud P., Maass K., Eickelberg O., Margetts P.J., Warburton D., et al. Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1 but not TGF-beta3. Int J Biochem Cell Biol 40 (2008) 484-495
21. Decologne N., Kolb M., Margetts P.J., Menetrier F., Artur Y., Garrido C., et al. TGF-beta1 induces progressive pleural scarring and subpleural fibrosis. J Immunol 179 9 (2007) 6043-6051
22. Kolb M., Bonniaud P., Galt T., Sime P.J., Kelly M.M., Margetts P.J., et al. Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of "fibrosis-prone" and "fibrosis-resistant" mouse strains. Am J Respir Cell Mol Biol 27 2 (2002) 141-150
23. Cantaluppi V., Biancone L., Romanazzi G.M., Figliolini F., Beltramo S., Ninniri M.S., et al. Antiangiogenic and immunomodulatory effects of rapamycin on islet endothelium: relevance for islet transplantation. Am J Transplant 6 11 (2006) 2601-2611
24. McGuigan A.P., and Sefton M.V. Design criteria for a modular tissue-engineered construct. Tissue Eng 13 5 (2007) 1079-1089
25. Ahsan T., and Nerem R.M. Bioengineered tissues: the science, the technology, and the industry. Orthod Craniofac Res 8 3 (2005) 134-140
26. Budzynski W., and Radzikowski C. Cytotoxic cells in immunodeficient athymic mice. Immunopharmacol Immunotoxicol 16 3 (1994) 319-346
27. Jones K.S., Sefton M.V., and Gorczynski R.M. In vivo recognition by the host adaptive immune system of microencapsulated xenogeneic cells. Transplantation 78 10 (2004) 1454-1462
28. Gill R.G. The role of direct and indirect antigen presentation in the response to islet xenografts. Transplant Proc 24 2 (1992) 642-643
29. Jones K.S., Sefton M.V., and Gorczynski R.M. Suppressed splenocyte proliferation following a xenogeneic skin graft due to implanted biomaterials. Transplantation 82 3 (2006) 415-421
30. Babensee J.E., and Paranjpe A. Differential levels of dendritic cell maturation on different biomaterials used in combination products. J Biomed Mater Res A 74 4 (2005) 503-510
31. Yoshida M., and Babensee J.E. Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation. J Biomed Mater Res A 79 2 (2006) 393-408
32. Yates S.F., Paterson A.M., Nolan K.F., Cobbold S.P., Saunders N.J., Waldmann H., et al. Induction of regulatory T cells and dominant tolerance by dendritic cells incapable of full activation. J Immunol 179 2 (2007) 967-976
33. Padovan E., Landmann R.M., and De L.G. How pattern recognition receptor triggering influences T cell responses: a new look into the system. Trends Immunol 28 7 (2007) 308-314
34. Dillon S., Agrawal S., Banerjee K., Letterio J., Denning T.L., Oswald-Richter K., et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Invest 116 4 (2006) 916-928
35. Ochando J.C., Homma C., Yang Y., Hidalgo A., Garin A., Tacke F., et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol 7 6 (2006) 652-662
36. Mazariegos G.V., Zahorchak A.F., Reyes J., Ostrowski L., Flynn B., Zeevi A., et al. Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant 3 6 (2003) 689-696
37. Guardino A.E., Rajapaksa R., Ong K.H., Sheehan K., and Levy R. Production of myeloid dendritic cells (DC) pulsed with tumor-specific idiotype protein for vaccination of patients with multiple myeloma. Cytotherapy 8 3 (2006) 277-289
38. Goulmy E., Stijnen T., Groenewoud A.F., Persijn G.G., Blokland E., Pool J., et al. Renal transplant patients monitored by the cell-mediated lympholysis assay: evaluation of its clinical value. Transplantation 48 4 (1989) 559-563
39. Strober S., Benike C., Krishnaswamy S., Engleman E.G., and Grumet F.C. Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity. Transplantation 69 8 (2000) 1549-1554
40. Zhao Y., and Li X.C. Transplant tolerance: is it really free of concerns?. Trends Immunol 28 9 (2007) 376-377
41. Hunt J.A., Flanagan B.F., McLaughlin P.J., Strickland I., and Williams D.F. Effect of biomaterial surface charge on the inflammatory response: evaluation of cellular infiltration and TNF-alpha production. J Biomed Mater Res 31 1 (1996) 139-144
42. Nilsson B., Ekdahl K.N., Mollnes T.E., and Lambris J.D. The role of complement in biomaterial-induced inflammation. Mol Immunol 44 1-3 (2007) 82-94
43. Mollnes T.E. Complement and biocompatibility. Vox Sang 74 Suppl. 2 (1998) 303-307
44. Gorbet M.B., and Sefton M.V. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 25 26 (2004) 5681-5703
45. Longhi M.P., Harris C.L., Morgan B.P., and Gallimore A. Holding T cells in check: a new role for complement regulators?. Trends Immunol 27 2 (2006) 102-108
46. McGettrick A.F., and O'Neill L.A. Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis. Br J Haematol 139 2 (2007) 185-193
47. Kabelitz D. Expression and function of Toll-like receptors in T lymphocytes. Curr Opin Immunol 19 1 (2007) 39-45
48. Otsuka H., Ikeya T., Okano T., and Kataoka K. Activation of lymphocyte proliferation by boronate-containing polymer immobilised on substrate: the effect of boron content on lymphocyte proliferation. Eur Cell Mater 12 (2006) 36-43
49. Krammer P.H., Arnold R., and Lavrik I.N. Life and death in peripheral T cells. Nat Rev Immunol 7 7 (2007) 532-542
50. Game D.S., and Lechler R.I. Pathways of allorecognition: implications for transplantation tolerance. Transpl Immunol 10 2/3 (2002) 101-108
51. Ardehali A., Fischbein M.P., Yun J., Irie Y., Fishbein M.C., and Laks H. Indirect alloreactivity and chronic rejection. Transplantation 73 11 (2002) 1805-1807
52. Afzali B., Lombardi G., Lechler R.I., and Lord G.M. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 148 1 (2007) 32-46
53. Derks R.A., and Burlingham W.J. In vitro parameters of donor-antigen-specific tolerance. Curr Opin Immunol 17 5 (2005) 560-564
54. Carrodeguas L., Orosz C.G., Waldman W.J., Sedmak D.D., Adams P.W., and VanBuskirk A.M. Trans vivo analysis of human delayed-type hypersensitivity reactivity. Hum Immunol 60 8 (1999) 640-651
55. VanBuskirk A.M., Burlingham W.J., Jankowska-Gan E., Chin T., Kusaka S., Geissler F., et al. Human allograft acceptance is associated with immune regulation. J Clin Invest 106 1 (2000) 145-155
56. Bickerstaff A.A., VanBuskirk A.M., Wakely E., and Orosz C.G. Transforming growth factor-beta and interleukin-10 subvert alloreactive delayed-type hypersensitivity in cardiac allograft acceptor mice. Transplantation 69 7 (2000) 1517-1520
57. Geissler F., Jankowska-Gan E., Sollinger H., Kalayoglu M., VanBuskirk A.M., Orosz C.G., et al. Immunoregulation in liver transplant recipients: possible evidence of tolerance by DTH assay. Transplant Proc 33 1/2 (2001) 1377
58. Xu Q., Lee J., Jankowska-Gan E., Schultz J., Roenneburg D.A., Haynes L.D., et al. Human CD4+CD25 low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance. J Immunol 178 6 (2007) 3983-3995